Intended Use
Use for diagnosis, prognosis, and monitoring of hematopoietic neoplasms.
Patient Preparation
- Sample collection: Non-diluted bone marrow aspirate (or) Peripheral Blood collected in a sodium heparinized Vacutainer.
- Specimen preparation: Do not freeze or expose to extreme temperatures.
- Bone Marrow: Transfer 3 mL bone marrow to a Green (Sodium Heparin). (Min: 1 mL)
- Whole Blood: Transport 5 mL whole blood. (Min: 2 mL)
- Storage/Transport Temperature: Room temperature.
- Unacceptable Conditions: Frozen specimens. Clotted specimens.
- Remarks:
- Stability: Ambient: 48 hours; Refrigerated: 48 hours; Frozen: Unacceptable
Methodology
Giemsa Banding
Sample received to report Turnaround time (TAT)
21 working days
Reference Interval
——————
Interpretive Data
ISCN 2024 and the most recent WHO classification of Tumours of Hematopoietic and Lymphoid Tissues (Revised 5th edition) is used for interpretation criteria for evaluation.
Resources
Sample Reports
Note: These studies involve culturing of living cells; therefore, turnaround times given represent average
times, which are subject to multiple variables. This test must be ordered using Oncology test request form